Amgen’s Sell Rating: Declining EPS and Overvalued Stock Amid Modest Revenue Growth
In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a ...
stocknews8h
3 Biotech Stocks Revolutionizing Healthcare
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress
Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a ...
bovnews1d
What’s Causing Amgen Inc (AMGN) Stock’s -16.29% Drop Over the Last Six Months?
Amgen Inc (AMGN) stock saw a decline, ending the day at $280.3 which represents a decrease of $-2.65 or -0.94% from the prior close of $282.95. The stock opened at $280.13 and touched a low of $279.97 ...
General purpose AI could lead to array of new risks, experts say in report ahead of AI summit
A new report says advanced artificial intelligence systems have the potential to create extreme new risks, such as fueling ...